Webinar Highlights
In this webinar, the speakers will cover :
- protein crystallography and its importance in drug discovery.
- challenges in crystallography, structural biology and gene-to-structure for drug discovery and protein engineering.
- significance of our high-throughput crystallography for drug discovery.
- hit generation in drug discovery with our crystallography-based library screening.
- interfacing crystallography with biophysics, medicinal and computational chemistry, biology and our AI in drug discovery.
Featuring Insights from
Tom Pesnot
,
PhD
Thomas (Tom) Pesnot, PhD is Drug Discovery Services Director at Concept Life Sciences since 2024. He has gained over 15 years' experience of leading drug discovery programmes in the academic, biotech, and CRO sectors, and contributed to the development of multiple clinical candidates and marketed drugs.
Debanu Das
,
PhD
Debanu has over 20 years of experience in high-throughput protein X-ray crystallography, structure-and fragment-based drug discovery and structural biology. His expertise includes structure-function analysis of a broad range of proteins and drug targets (kinases, proteases, antibody-antigen complexes, nuclear receptors, ubiquitin ligases, methylases, polymerases, microbiome enzymes, membrane proteins, transcription factors).
Sponsored by
.png)
